Lymphedema Circulatory System Lymphoedema, not elsewhere classified
Conditions
Interventions
Women diagnosed with mild arm lymphedema are consecutively randomized to the non-compression (NCG) group or compression group (CG) at the Lymphedema Unit, Skåne University Hospital and at the Physioth
Sponsors
Lund University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Women treated for unilateral breast cancer 2. Axillary node dissection 3. Diagnosed with mild arm lymphedema
Exclusion criteria
Exclusion criteria: 1. Recurrent breast cancer 2. Concurrent diseases that could interfere with the measurement of lymphedema 3. Cognitive disability 4. Language difficulties making it hard to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The number (proportion) of women with mild breast cancer-related lymphedema BCRL (defined as Lymphedema Relative Volume [LRV] 2% from start or anytime exceeding LRV >10%, measured by the water displacement method (WDM) at baseline and after 1, 2, 3 and 6 months 2. Health-related quality of life (HRQL) measured using the Lymphedema Quality of Life Inventory (LyQLI) at 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Arm volume measured by the water displacement method (WDM), local tissue water by Tissue Dielectric Constant (TDC) and subjective symptoms of pain, tension, and heaviness by Visual Analogue Scale (VAS) at baseline and 1, 2, 3, and 6 months 2. Background data including surgical methods and adjuvant treatments collected from medical records and a study-specific questionnaire at baseline 3. Frequency of self-rated physical activity level/exercise and housework collected from a study-specific questionnaire at baseline and at 6 months 4. Frequency of use of compression and performance of simple lymphatic drainage collected from a study-specific questionnaire at 6 months | — |
Countries
Sweden
Outcome results
None listed